FDA Approves Prostate Cancer Drug Jevtana in Eleven Weeks
Links shared publicly online about this topic.
- 1,074total visits
FDA Approves Prostate Cancer Drug Jevtana in Eleven Weeks
Sanofi-Aventis’ prostate cancer drug Jevtana will launch this summer following an earlier-than-expected FDA approval.
View full resource at fdanews.com
Tags: Cancer, Cancer Medication, Prostate Cancer, Prostate Cancer Medication, Prostate, Drug, Men's Health, FDA
Most Recently Shared on June 23, 2010 at 12:41 am By:
FDA Approves Prostate Cancer Drug Jevtana in Eleven Weeks http://bit.ly/cfQPGB
Advertisement
